Plasma Cell Dyscrasias and Engineered Cellular Therapy: Is a Cure in Sight?
Back to course
Video Transcription
Video Summary
Asset Caption
Hamza Hashmi, MD
Meta Tag
Speaker Hamza Hashmi
Keywords
multiple myeloma
CRAB criteria
SLiM biomarkers
MRD testing
CAR T-cell therapy
bispecific antibodies
transplant eligibility